Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2003
03/27/2003US20030059793 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
03/27/2003US20030059473 Method for preparing colloidal particles in the form of nanocapsules
03/27/2003US20030059469 Protecting the carboxylic acid group of the drug molecule, adding to the drug molecule a chlorinated polyanhydride linker, deprotecting by exposing the linked drug molecules to heat or vacuum, acetylating to produce monomer, polymerizing
03/27/2003US20030059455 A defective recombinant adenovirus including at least one DNA sequence coding for all or an active part of a superoxide; useful for treating and/or preventing Parkinson's disease, Alzheimer's disease, Huntington's disease etc.
03/27/2003US20030059423 Method for treating symptoms of diabetes
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030059414 Cell populations which co-express CD49c and CD90
03/27/2003US20030059397 Solid oral dosage forms of controlled substances having reduced potential for abuse by inhalation, mastication, and injection; for alternative administration of oxycodone
03/27/2003US20030059369 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
03/27/2003US20030057193 Method for forming a via hole, flexible wiring board using the method, and method for producing the flexible wiring board
03/27/2003CA2709442A1 Cell populations which co-express cd49c and cd90
03/27/2003CA2461176A1 Treatment of central nervous system disorders by use of pdgf or vegf
03/27/2003CA2460985A1 Nestin-expressing hair follicle stem cells
03/27/2003CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460704A1 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003CA2460578A1 Propanolamine derivative having 1,4-benzodioxane ring
03/27/2003CA2460544A1 Anti-inflammatory agent
03/27/2003CA2460445A1 7-tert-butyl-3-(2-fluorophenyl)-6-(2h-(1,2,4)triazol-3-ylmethoxy)-(1,2,4)triazolo (4,3-b) pyridazine for the treatment of anxiety and convulsions
03/27/2003CA2460334A1 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2003CA2460184A1 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof
03/27/2003CA2460126A1 Tricyclic indole derivatives as 5-ht ligands
03/27/2003CA2460098A1 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
03/27/2003CA2459969A1 Autologous t-cell vaccines materials and methods
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459137A1 Receptors and membrane-associated proteins
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2458720A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatment
03/26/2003EP1295885A1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
03/26/2003EP1295884A1 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives
03/26/2003EP1295883A1 Medicines for the prevention and treatment of neurodegenerative diseases
03/26/2003EP1295865A1 Novel dicarboxylic acid derivatives
03/26/2003EP1295608A1 Remedial agent for anxiety neurosis or depression and piperazine derivative
03/26/2003EP1295604A1 Preventives and remedies for diseases in association with demyelination
03/26/2003EP1295598A1 Pharmaceutical composition containing two active ingredients for smoking cessation
03/26/2003EP1295527A1 Mouse showing neurofibril change due to senile dementia
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294901A2 Novel proteases
03/26/2003EP1294895A2 Calpain protease 12
03/26/2003EP1294887A1 Insulin homolog polypeptide zins4
03/26/2003EP1294884A2 Secretion and trafficking molecules
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294868A2 Adenylyl and guanylyl cyclases
03/26/2003EP1294856A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE
03/26/2003EP1294770A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294759A1 Prion-binding activity in serum and plasma determined as plasminogen and fibrinogen
03/26/2003EP1294758A2 Regulation of human substance p-like g protein-coupled receptor
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294744A2 Peptides that stimulate cell survival and axon regeneration
03/26/2003EP1294743A2 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis
03/26/2003EP1294735A2 Methods and compositions for treating flaviviruses and pestiviruses
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294726A2 Improvements in and relating to chromophores
03/26/2003EP1294725A2 Multicyclic compounds and the use thereof as inhibitors of parp, vegfr2 and mlk3 enzymes
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294723A1 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
03/26/2003EP1294722A2 Methods of synthesis for 9-substituted hypoxanthine derivatives
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294710A1 Indole derivatives useful for the treatment of cns disorders
03/26/2003EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/26/2003EP1294702A1 Benzodiazepine derivatives as app modulators
03/26/2003EP1294701A2 Bis-arylsulfones
03/26/2003EP1294700A2 Benzhydryl derivatives
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294698A1 Fused azepine derivatives and their use as antidiuretic agents
03/26/2003EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294677A1 Benzophenones and sulfones as inhibitors of glycine uptake
03/26/2003EP1294659A2 Process for isolating enantiomers of racemic cetamine
03/26/2003EP1294409A2 Membrane-permeant peptide complexes for medical imaging
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP1294390A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
03/26/2003EP1294389A1 THERAPEUTICAL USE OF i SOPHORA FLAVESCENS /i OR i SOPHORA SUBPROSTRATA /i EXTRACTS
03/26/2003EP1294388A1 EXTRACTS FROM i SOPHORA /i SPECIES, METHOD FOR PRODUCING THE SAME AND THEIR USE
03/26/2003EP1294382A1 7-hydroxyepiandrosterone having neuroprotective activity
03/26/2003EP1294381A1 Neuroprotective 7-beta-hydroxysteroids
03/26/2003EP1294377A2 Methods and compositions for the treatment of alcoholism and alcohol dependence
03/26/2003EP1294376A2 Medicament for combating respiratory depression
03/26/2003EP1294369A1 NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE
03/26/2003EP1294364A1 Stable gabapentin having ph within a controlled range
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1181010A4 Pharmaceutical chewing gum formulations
03/26/2003EP1173215A4 Over-coated chewing gum formulations
03/26/2003EP1159274B1 Method for the preparation of citalopram
03/26/2003EP1124559B1 Compositions for the treatment and prevention of neurological and pathopsychological diseases
03/26/2003EP1119366B1 Animal stereotypy
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1086249B1 Diagnostic method based on quantification of extramitochondrial dna
03/26/2003EP1075263B1 Aqueous process for manufacturing paroxetine solid dispersions
03/26/2003EP1027325B1 Lipophilic diesters of chelating agents
03/26/2003EP1021432B1 Halogen substituted tetracyclic tetrahydrofuran derivatives
03/26/2003EP0970080B1 Imino-aza-anthracyclinone derivatives for the treatment of amyloidosis
1 ... 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 ... 1833